Abstract: Disclosed are a battery and an electronic device, including a housing, a sealing cover, and a battery cell. The housing has an accommodation cavity, and the battery cell is located in the accommodation cavity. The housing is provided with a liquid injection hole. An upper surface of a peripheral edge of the sealing cover is provided with a first step, and the first step divides the sealing cover into a first cover area and a second cover area. The thickness of the second cover area is less than or equal to a thickness of the housing at a seal-welding position with the second cover area. The battery provided in embodiments of the present disclosure has good seal-welding performance, to resolve problems of low battery yields, difficulty in mass production, and failure to achieve expected safety and stability due to poor seal-welding performance.

Abstract: The present application provides a battery including a shell, a top cover, a battery cell, and a second adapter part. The top cover seals an upper end of the shell and forms a cavity together with the shell, and the battery cell is located in the cavity. The shell includes a side wall surrounding the cavity and a bottom shell arranged at a lower end of the side wall. The battery cell has a first tab and a second tab, the bottom shell is electrically connected to the second tab, the second adapter part includes a second connection sheet and a second pin, the second adapter part is connected to the bottom shell through the second connection sheet; one end of the second pin is connected to the second connection sheet, and the other end thereof extends out of an outer edge of the bottom shell.

Abstract: Disclosed is a battery, the battery including a housing, where the housing is a metal piece, the housing includes a bottom shell and a cap, and the cap covers an opening of the bottom shell; the cap includes a mounting hole, a conductive sealing pin disposed in the mounting hole, a side periphery of the sealing pin is provided with a clamping groove, and the cap close to the mounting hole extends into the clamping groove and is in clamped connection to the clamping groove; and a seal is provided at a connection between the clamping groove and the cap, and the seal is an electrical insulator. The structure improves application stability of the battery and improves sealing performance and safety of the battery.

Abstract: The present application provides a button cell and its manufacturing method and electronic equipment. The button cell includes a housing, an electrode assembly and a covering member, an accommodating cavity being provided in the housing, the electrode assembly being located in the accommodating cavity, the housing having a liquid injection hole for injecting electrolyte into the accommodating cavity; an outer surface of the housing having a recessed portion that is recessed towards an inner side of the accommodating cavity, the recessed portion being located at a orifice of the liquid injection hole and communicated with the liquid injection hole; and the covering member being welded to the outer side of the housing to cover the recessed portion and the liquid injection hole. The button cell and its manufacturing method and electronic equipment of the present.

Abstract: A battery case, a battery, and an electronic device include a case body, a first cover body, a first insulating part, and a second cover body, where the case body includes a bottom wall and a side wall connected to the bottom wall; the first cover body includes a first surface and a second surface disposed opposite to each other; the second cover body includes a third surface and a fourth surface disposed opposite to each other; the first surface of the first cover body is connected to one end of the side wall away from the bottom wall, and the second surface of the first cover body is connected to the third surface of the second cover body by the first insulating part.

Abstract: The present invention relates to methods, kits, and compositions for detecting and/or diagnosing metastatic potential of cancer cells or for evaluating prognosis in a patient with cancer by detection of the protein expression level of an HLA class I molecule and/or the copy number variation of a polynucleotide encoding the HLA class I molecule. The present invention also relates to the use of the protein expression level of an HLA class I molecule and/or the copy number variation of a polynucleotide encoding the HLA class I molecule as a prognosis biomarker and metastasis predictive biomarker of cancer.

Abstract: The present invention relates to methods, kits, and compositions for detecting and/or diagnosing metastatic potential of cancer cells or for evaluating prognosis in a patient with cancer by detection of the protein expression level of an HLA class I molecule and/or the copy number variation of a polynucleotide encoding the HLA class I molecule. The present invention also relates to the use of the protein expression level of an HLA class I molecule and/or the copy number variation of a polynucleotide encoding the HLA class I molecule as a prognosis biomarker and metastasis predictive biomarker of cancer.

Abstract: The present invention relates to methods, kits, and compositions for detecting and/or diagnosing metastatic potential of cancer cells or for evaluating prognosis in a patient with cancer by detection of the protein expression level of an HLA class I molecule and/or the copy number variation of a polynucleotide encoding the HLA class I molecule. The present invention also relates to the use of the protein expression level of an HLA class I molecule and/or the copy number variation of a polynucleotide encoding the HLA class I molecule as a prognosis biomarker and metastasis predictive biomarker of cancer.

Abstract: The present invention relates to methods, kits, and compositions for detecting and/or diagnosing metastatic potential of cancer cells or for evaluating prognosis in a patient with cancer by detection of the protein expression level of an HLA class I molecule and/or the copy number variation of a polynucleotide encoding the HLA class I molecule. The present invention also relates to the use of the protein expression level of an HLA class I molecule and/or the copy number variation of a polynucleotide encoding the HLA class I molecule as a prognosis biomarker and metastasis predictive biomarker of cancer.